Healthcare
Valuation and diligence across providers, medtech and life sciences.
Sector drivers
- Reimbursement and regulatory change
- R&D pipelines and milestone risk
- M&A and consolidation
Typical assets & workflows
- Business enterprise and practices
- Patents, devices and diagnostics IP
- Licences and regulatory intangibles
Standards & regulation
- ASC 805 / IFRS 3 (PPA)
- ASC 350 / IAS 36 (impairment)
- IFRS 13 and IVS 2025
Key measures
- Revenue per practitioner or bed
- Pipeline milestones
- EBITDA margin and payor mix
Our approach
We value practices, devices and pipeline IP using risk-adjusted income methods, testing reimbursement and milestone assumptions that drive value in the sector.